(2-Methoxy-3,5-dimethylpyridin-4-yl)boronic acid, 98%, 250mg

3-G1 2AB (500pmol/vial)1vial

2-Chloro-1,3-difluoro-4-trifluoromethyl-benzene, 95.0%, 1g

2-(1,3,2-Dioxaborinan-2-yl)benzamide, 97%, 1g

(1R,4R)-4-(((tert-Butoxycarbonyl)(methyl)amino)methyl)cyclohexanecarboxylic acid, 95.0%, 1g

5-CHLORO-1-METHYLINDOLIN-2-ONE, 95%, 250mg

Solución de hidróxido de sodio al 25%, extra pura, 1 l, envase de plástico.

6-Chloro-2-nitropyridin-3-ol, 95.0%, 1g

tert-Butyl (2-((4-chlorobenzyl)amino)ethyl)carbamate, 95.0%, 1g

Methyl 1-methyl-1H-indole-5-carboxylate, 95.0%, 250mg

1-Phenylcyclopropan-1-ol, 98+%, 1g

Methyl 4-(2-Hydroxyethoxy)benzoate>98.0%(GC)25g

(2S,4R)-tert-Butyl 4-hydroxy-2-methylpyrrolidine-1-carboxylate, 95.0%, 10g